Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4876
First Trust Mid Cap Core AlphaDEX Fund
FNX
$1.42B
| $2.87M | ﹤0.01% |
+24,801
| New | +$2.97M |
|
4877
CALL
Simpson Manufacturing
SSD
$7.94B
| $2.87M | ﹤0.01% |
17,300
-11,300
| -40% | -$2.07M |
|
4878
Weis Markets
WMK
$1.76B
| $2.87M | ﹤0.01% |
42,320
+15,408
| +57% | +$1.06M |
|
4879
CALL
Vaxcyte
PCVX
$8.64B
| $2.87M | ﹤0.01% |
35,000
+5,100
| +17% | +$506K |
|
4880
Noble Corp
NE
$7.2B
| $2.86M | ﹤0.01% |
91,197
+90,778
| +21,665% | +$3M |
|
|
OSG
4881
CALL
Octave Specialty Group
OSG
$221M
| $2.86M | ﹤0.01% |
226,300
-37,300
| -14% | -$450K |
|
|
DSL
4882
DoubleLine Income Solutions Fund
DSL
$1.24B
| $2.86M | ﹤0.01% |
227,733
+220,678
| +3,128% | +$2.81M |
|
4883
CALL
Woodward
WWD
$21.9B
| $2.86M | ﹤0.01% |
17,200
-8,400
| -33% | -$1.44M |
|
4884
CALL
Qualys
QLYS
$6.44B
| $2.86M | ﹤0.01% |
20,400
+4,000
| +24% | +$557K |
|
|
FFWM
4885
DELISTED
First Foundation Inc
FFWM
| $2.86M | ﹤0.01% |
460,519
-79,479
| -15% | -$574K |
|
4886
PUT
Lantheus
LNTH
$6.59B
| $2.85M | ﹤0.01% |
31,900
-2,200
| -6% | -$214K |
|
4887
Comstock Resources
CRK
$4.13B
| $2.85M | ﹤0.01% |
156,417
-93,283
| -37% | -$1.29M |
|
4888
PUT
iShares US Aerospace & Defense ETF
ITA
$15.1B
| $2.85M | ﹤0.01% |
19,600
+8,400
| +75% | +$1.27M |
|
|
CGC
4889
CALL
Canopy Growth
CGC
$431M
| $2.85M | ﹤0.01% |
1,038,730
-1,176,650
| -53% | -$4.67M |
|
4890
SiTime
SITM
$21.4B
| $2.84M | ﹤0.01% |
13,253
-779
| -6% | -$159K |
|
4891
CALL
Autoliv
ALV
$8.94B
| $2.84M | ﹤0.01% |
30,300
-6,500
| -18% | -$625K |
|
4892
CALL
Vanguard Health Care ETF
VHT
$18.9B
| $2.84M | ﹤0.01% |
11,200
-900
| -7% | -$242K |
|
4893
PUT
Kornit Digital
KRNT
$775M
| $2.84M | ﹤0.01% |
91,800
-37,000
| -29% | -$1.06M |
|
4894
PUT
PubMatic
PUBM
$801M
| $2.84M | ﹤0.01% |
193,100
-24,300
| -11% | -$377K |
|
4895
CALL
Globant
GLOB
$1.61B
| $2.83M | ﹤0.01% |
13,200
-10,400
| -44% | -$2.27M |
|
4896
Relay Therapeutics
RLAY
$4.35B
| $2.83M | ﹤0.01% |
686,878
-2,222,493
| -76% | -$12.1M |
|
4897
PUT
Viridian Therapeutics
VRDN
$2.5B
| $2.83M | ﹤0.01% |
147,600
+100,400
| +213% | +$2.18M |
|
4898
CALL
MakeMyTrip
MMYT
$5.68B
| $2.83M | ﹤0.01% |
25,200
-70,300
| -74% | -$7.53M |
|
4899
PUT
Viasat
VSAT
$11.4B
| $2.83M | ﹤0.01% |
332,100
+170,200
| +105% | +$1.64M |
|
4900
Xeris Biopharma Holdings
XERS
$1.57B
| $2.82M | ﹤0.01% |
+833,328
| New | +$2.68M |
|
Similar funds
Ken Griffin's Q4 2024 Portfolio in Review
As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
- Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
- Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.